JP2002505672A - 水溶液中における保護されていないか又はn−末端システインで保護されたペプチドの固相での自然化学連結 - Google Patents
水溶液中における保護されていないか又はn−末端システインで保護されたペプチドの固相での自然化学連結Info
- Publication number
- JP2002505672A JP2002505672A JP50326799A JP50326799A JP2002505672A JP 2002505672 A JP2002505672 A JP 2002505672A JP 50326799 A JP50326799 A JP 50326799A JP 50326799 A JP50326799 A JP 50326799A JP 2002505672 A JP2002505672 A JP 2002505672A
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- solid phase
- terminal
- segment
- unprotected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/08—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents
- C07K1/086—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using activating agents containing sulfur
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
- C07K1/023—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution using racemisation inhibiting agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
- C07K1/026—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution by fragment condensation in solution
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4955397P | 1997-06-13 | 1997-06-13 | |
| US60/049,553 | 1997-06-13 | ||
| PCT/US1998/012278 WO1998056807A1 (en) | 1997-06-13 | 1998-06-12 | Solid phase native chemical ligation of unprotected or n-terminal cysteine protected peptides in aqueous solution |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002505672A true JP2002505672A (ja) | 2002-02-19 |
| JP2002505672A5 JP2002505672A5 (cg-RX-API-DMAC10.html) | 2005-12-22 |
Family
ID=21960431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50326799A Ceased JP2002505672A (ja) | 1997-06-13 | 1998-06-12 | 水溶液中における保護されていないか又はn−末端システインで保護されたペプチドの固相での自然化学連結 |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US6326468B1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1001968B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2002505672A (cg-RX-API-DMAC10.html) |
| AT (2) | ATE354584T1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU745094B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2292724A1 (cg-RX-API-DMAC10.html) |
| DE (2) | DE69837170T2 (cg-RX-API-DMAC10.html) |
| ES (2) | ES2235336T3 (cg-RX-API-DMAC10.html) |
| WO (1) | WO1998056807A1 (cg-RX-API-DMAC10.html) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007046456A1 (ja) * | 2005-10-19 | 2007-04-26 | Chugai Seiyaku Kabushiki Kaisha | 新規水溶性プロドラッグを含有する、膵臓癌、卵巣癌または肝臓癌の予防または治療剤 |
| US7910593B2 (en) | 2004-04-09 | 2011-03-22 | Chugai Seiyaku Kabushiki Kaisha | Water-soluble prodrugs |
| US8022047B2 (en) | 2005-08-22 | 2011-09-20 | Chugai Seiyaku Kabushiki Kaisha | Combination anticancer agents |
| JP2014532075A (ja) * | 2011-10-17 | 2014-12-04 | サントル ナシオナル ドゥ ラ ルシェルシェサイアンティフィク(セエヌエールエス) | タンパク質の合成方法 |
| KR20210098466A (ko) * | 2018-11-30 | 2021-08-10 | 가부시키가이샤 도우사 고가쿠 겐큐쇼 | 펩티드 티오에스테르 및 펩티드의 신규 제조 방법 |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6184344B1 (en) * | 1995-05-04 | 2001-02-06 | The Scripps Research Institute | Synthesis of proteins by native chemical ligation |
| US6849428B1 (en) * | 1997-03-05 | 2005-02-01 | New England Biolabs, Inc. | Intein-mediated protein ligation of expressed proteins |
| DE69837170T2 (de) * | 1997-06-13 | 2007-11-22 | Amylin Pharmaceuticals, Inc., San Diego | Festphasige native chemische Ligation von ungeschützten oder n-cystein-geschützten Peptiden in wässrigen Lösungen |
| US6844161B2 (en) | 1997-09-04 | 2005-01-18 | Gryphon Therapeutics, Inc. | Modular protein libraries and methods of preparation |
| AUPP589598A0 (en) | 1998-09-14 | 1998-10-08 | University Of Queensland, The | Novel peptides |
| US7001745B1 (en) * | 1998-09-30 | 2006-02-21 | New England Biolabs, Inc. | Intein mediated peptide ligation |
| EP1159289A1 (en) * | 1999-03-11 | 2001-12-05 | Gryphon Sciences | Chemical synthesis and use of soluble membrane protein receptor domains |
| SK782002A3 (en) | 1999-07-21 | 2003-08-05 | Lexigen Pharm Corp | FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens |
| EP1307214A4 (en) * | 2000-08-11 | 2006-01-18 | Invitrogen Corp | HIGHLY HOMOGENEOUS MOLECULAR MARKERS FOR ECTROPHORESIS |
| US20040014082A1 (en) * | 2000-08-11 | 2004-01-22 | Invitrogen Corporation | Highly homogeneous molecular markers for electrophoresis |
| US6977292B2 (en) * | 2000-09-01 | 2005-12-20 | Gryphon Therapeutics | Nucleophile-stable thioester generating compounds, methods of production and use |
| US7273923B2 (en) * | 2001-01-22 | 2007-09-25 | Sangamo Biosciences, Inc. | Zinc finger proteins for DNA binding and gene regulation in plants |
| ATE346950T1 (de) * | 2001-03-09 | 2006-12-15 | Boston Probes Inc | Kombinationsoligomere betreffende verfahren, kits und zusammensetzungen |
| GB0113657D0 (en) * | 2001-06-05 | 2001-07-25 | Geneprot Inc | Improved native chemical ligation with three or more components |
| EP2292273A3 (en) | 2001-10-10 | 2011-11-23 | BioGeneriX AG | Remodeling and glycoconjugation of peptides |
| WO2003106615A2 (en) * | 2002-06-10 | 2003-12-24 | Geneprot, Inc. | Post-cleavage sulfur deprotection for convergent protein synthesis by chemical ligation |
| ATE312605T1 (de) * | 2002-06-29 | 2005-12-15 | Aquanova Ger Solubilisate Tech | Isoflavonkonzentrate sowie verfahren zu ihrer herstellung |
| US7166574B2 (en) * | 2002-08-20 | 2007-01-23 | Biosurface Engineering Technologies, Inc. | Synthetic heparin-binding growth factor analogs |
| US7598224B2 (en) | 2002-08-20 | 2009-10-06 | Biosurface Engineering Technologies, Inc. | Dual chain synthetic heparin-binding growth factor analogs |
| US8227411B2 (en) | 2002-08-20 | 2012-07-24 | BioSurface Engineering Technologies, Incle | FGF growth factor analogs |
| WO2004053460A2 (en) * | 2002-12-11 | 2004-06-24 | New England Biolabs, Inc. | Carrier-ligand fusions and uses thereof |
| US8034900B2 (en) * | 2002-12-30 | 2011-10-11 | Amylin Pharmaceuticals, Inc. | Water-soluble thioester and selenoester compounds and methods for making and using the same |
| CA2522345A1 (en) | 2003-04-09 | 2004-11-18 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
| US7348004B2 (en) | 2003-05-06 | 2008-03-25 | Syntonix Pharmaceuticals, Inc. | Immunoglobulin chimeric monomer-dimer hybrids |
| TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
| SI1624891T2 (sl) * | 2003-05-06 | 2013-09-30 | Biogen Idec Hemophilia Inc. | Strjevalni faktor-FC himerni proteini za zdravljenje hemofilije |
| WO2004105685A2 (en) * | 2003-05-22 | 2004-12-09 | Gryphon Therapeutics, Inc. | Displaceable linker solid phase chemical ligation |
| US7414028B1 (en) | 2004-02-04 | 2008-08-19 | Biosurface Engineering Technologies, Inc. | Growth factor analogs |
| US20080227696A1 (en) | 2005-02-22 | 2008-09-18 | Biosurface Engineering Technologies, Inc. | Single branch heparin-binding growth factor analogs |
| US20060024347A1 (en) * | 2004-02-10 | 2006-02-02 | Biosurface Engineering Technologies, Inc. | Bioactive peptide coatings |
| US7671012B2 (en) | 2004-02-10 | 2010-03-02 | Biosurface Engineering Technologies, Inc. | Formulations and methods for delivery of growth factor analogs |
| US7528105B1 (en) | 2004-02-10 | 2009-05-05 | Biosurface Engineering Technologies | Heterodimeric chain synthetic heparin-binding growth factor analogs |
| JP4895826B2 (ja) | 2004-02-20 | 2012-03-14 | バイオサーフェス エンジニアリング テクノロジーズ,インク. | 骨形成蛋白−2の正のモジュレーター |
| EP1749022A2 (en) * | 2004-05-24 | 2007-02-07 | Rigel Pharmaceuticals, Inc. | Methods for cyclizing synthetic polymers |
| KR20080003849A (ko) | 2005-03-31 | 2008-01-08 | 아밀린 파마슈티칼스, 인크. | 비만 및 섭식 장애의 조절, 예방 및 치료를 위한 조성물 및방법 |
| US7674881B2 (en) * | 2005-10-07 | 2010-03-09 | The University Of Chicago | Convergent synthesis of proteins by kinetically controlled ligation |
| US7820172B1 (en) | 2006-06-01 | 2010-10-26 | Biosurface Engineering Technologies, Inc. | Laminin-derived multi-domain peptides |
| CA2692240C (en) | 2006-06-22 | 2018-03-13 | Biosurface Engineering Technologies, Inc. | Composition and method for delivery of bmp-2 amplifier/co-activator for enhancement of osteogenesis |
| EP2120985B1 (en) | 2007-02-05 | 2012-06-27 | Amylin Pharmaceuticals, Inc. | FN-38 peptides for use in the treatment of psychotic and anxiety disorders |
| WO2009032133A2 (en) * | 2007-08-28 | 2009-03-12 | Ipsen Pharma S.A.S. | Methods and intermediates for chemical synthesis of polypeptides and proteins |
| EP2536287A4 (en) * | 2010-02-18 | 2015-10-07 | Advanced Proteome Therapeutics Inc | SPECIFIC SITE SIZE OF PROTEINS USING CHEMICAL MODIFICATION TO PROMOTE PROTEIN CONJUGATE FORMATION, PROTEIN DIMER FORMATION, AND AGRAFTED PEPTIDES |
| MX349054B (es) | 2010-09-28 | 2017-07-07 | Aegerion Pharmaceuticals Inc | Leptinas altamente solubles. |
| BR112013007442A2 (pt) | 2010-09-28 | 2019-09-24 | Amylin Pharmaceuticals Llc | polipeptídeos construídos tendo duração de ação realçada |
| DK2729160T3 (da) | 2011-07-08 | 2019-07-01 | Aegerion Pharmaceuticals Inc | Manipulerede polypeptider, der har forbedret virkningstid og reduceret immunogenicitet |
| JP6006309B2 (ja) | 2011-07-08 | 2016-10-12 | アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc | 作用持続期間が増大し、免疫原性が減少した操作されたポリペプチド |
| US9545449B2 (en) | 2012-05-11 | 2017-01-17 | Advanced Proteone Therapeutics Inc. | Site-specific labeling and targeted delivery of proteins for the treatment of cancer |
| WO2013177231A1 (en) | 2012-05-21 | 2013-11-28 | Massachusetts Institute Of Technology | Translocation of non-natural chemical entities through anthrax protective antigen pore |
| SG11201505926VA (en) | 2013-03-15 | 2015-09-29 | Biogen Ma Inc | Factor ix polypeptide formulations |
| US11273176B2 (en) | 2016-03-02 | 2022-03-15 | The Brigham And Women's Hospital, Inc. | Use of PLA2G5-deficient suppressive macrophages in suppression of inflammation |
| EP3590951A4 (en) * | 2017-03-02 | 2021-01-06 | Glytech, Inc. | PROCESS FOR PRODUCING AN AMINO ACID POLYMER |
| KR20210072021A (ko) | 2018-10-01 | 2021-06-16 | 유니베르시떼 드 제네브 | 생물학 분석에 적합한 복수의 폴리펩티드 변이체의 생산 방법 |
| AU2020361681A1 (en) | 2019-10-10 | 2022-05-05 | 1859, Inc. | Methods and systems for microfluidic screening |
| US20210230218A1 (en) * | 2019-10-23 | 2021-07-29 | Mabplex International, Ltd. | Oligopeptide linker intermediate and preparation method thereof |
| WO2022266467A2 (en) | 2021-06-17 | 2022-12-22 | Dana-Farber Cancer Institute, Inc. | Recombinant histone polypeptide and uses thereof |
| WO2024146707A1 (en) | 2023-01-06 | 2024-07-11 | Université De Genève | Variant ligand conjugates for payload delivery |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5064940A (en) * | 1988-05-11 | 1991-11-12 | Protein Technologies, Inc. | Premixed dry reagent containing a protected amino acid and an activating agent for use in solid phase protein synthesis |
| US5101059A (en) * | 1989-12-05 | 1992-03-31 | Research Corporation Technologies, Inc. | Amino acid protecting groups |
| DK0832096T3 (da) * | 1995-05-04 | 2001-10-01 | Scripps Research Inst | Syntese af proteiner ved nativ kemisk ligering |
| JP4358307B2 (ja) * | 1996-12-24 | 2009-11-04 | ザ スクリップス リサーチ インスティテュート | 一般的化学結合 |
| DE69837170T2 (de) * | 1997-06-13 | 2007-11-22 | Amylin Pharmaceuticals, Inc., San Diego | Festphasige native chemische Ligation von ungeschützten oder n-cystein-geschützten Peptiden in wässrigen Lösungen |
| US6329468B1 (en) * | 2000-01-21 | 2001-12-11 | Bostik Findley, Inc. | Hot melt adhesive based on semicrystalline flexible polyolefins |
-
1998
- 1998-06-12 DE DE69837170T patent/DE69837170T2/de not_active Expired - Fee Related
- 1998-06-12 AT AT04029270T patent/ATE354584T1/de not_active IP Right Cessation
- 1998-06-12 US US09/097,094 patent/US6326468B1/en not_active Expired - Fee Related
- 1998-06-12 EP EP98929035A patent/EP1001968B1/en not_active Expired - Lifetime
- 1998-06-12 AT AT98929035T patent/ATE285415T1/de not_active IP Right Cessation
- 1998-06-12 ES ES98929035T patent/ES2235336T3/es not_active Expired - Lifetime
- 1998-06-12 CA CA002292724A patent/CA2292724A1/en not_active Abandoned
- 1998-06-12 JP JP50326799A patent/JP2002505672A/ja not_active Ceased
- 1998-06-12 DE DE69828287T patent/DE69828287T2/de not_active Expired - Fee Related
- 1998-06-12 ES ES04029270T patent/ES2282788T3/es not_active Expired - Lifetime
- 1998-06-12 WO PCT/US1998/012278 patent/WO1998056807A1/en not_active Ceased
- 1998-06-12 AU AU80695/98A patent/AU745094B2/en not_active Ceased
-
2001
- 2001-11-15 US US09/987,675 patent/US7030217B2/en not_active Expired - Fee Related
- 2001-11-15 US US09/987,655 patent/US7094871B2/en not_active Expired - Fee Related
-
2005
- 2005-05-03 US US11/119,831 patent/US20050209440A1/en not_active Abandoned
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7910593B2 (en) | 2004-04-09 | 2011-03-22 | Chugai Seiyaku Kabushiki Kaisha | Water-soluble prodrugs |
| US8022047B2 (en) | 2005-08-22 | 2011-09-20 | Chugai Seiyaku Kabushiki Kaisha | Combination anticancer agents |
| WO2007046456A1 (ja) * | 2005-10-19 | 2007-04-26 | Chugai Seiyaku Kabushiki Kaisha | 新規水溶性プロドラッグを含有する、膵臓癌、卵巣癌または肝臓癌の予防または治療剤 |
| JP2014532075A (ja) * | 2011-10-17 | 2014-12-04 | サントル ナシオナル ドゥ ラ ルシェルシェサイアンティフィク(セエヌエールエス) | タンパク質の合成方法 |
| KR20210098466A (ko) * | 2018-11-30 | 2021-08-10 | 가부시키가이샤 도우사 고가쿠 겐큐쇼 | 펩티드 티오에스테르 및 펩티드의 신규 제조 방법 |
| KR102769851B1 (ko) * | 2018-11-30 | 2025-02-20 | 가부시키가이샤 도우사 고가쿠 겐큐쇼 | 펩티드 티오에스테르 및 펩티드의 신규 제조 방법 |
Also Published As
| Publication number | Publication date |
|---|---|
| DE69837170T2 (de) | 2007-11-22 |
| DE69837170D1 (de) | 2007-04-05 |
| ATE285415T1 (de) | 2005-01-15 |
| AU8069598A (en) | 1998-12-30 |
| ES2235336T3 (es) | 2005-07-01 |
| WO1998056807A1 (en) | 1998-12-17 |
| US20020132975A1 (en) | 2002-09-19 |
| US7094871B2 (en) | 2006-08-22 |
| ATE354584T1 (de) | 2007-03-15 |
| AU745094B2 (en) | 2002-03-14 |
| US20050209440A1 (en) | 2005-09-22 |
| DE69828287D1 (de) | 2005-01-27 |
| CA2292724A1 (en) | 1998-12-17 |
| EP1001968A1 (en) | 2000-05-24 |
| US20020169282A1 (en) | 2002-11-14 |
| ES2282788T3 (es) | 2007-10-16 |
| EP1001968B1 (en) | 2004-12-22 |
| US6326468B1 (en) | 2001-12-04 |
| DE69828287T2 (de) | 2005-12-15 |
| US7030217B2 (en) | 2006-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1001968B1 (en) | Solid phase native chemical ligation of unprotected or n-terminal cysteine protected peptides in aqueous solution | |
| EP1392718B1 (en) | Improved native chemical ligation with three or more components | |
| US4786684A (en) | Benzylthioether-linked solid support-bound thiol compounds and method for peptide synthesis | |
| CZ80399A3 (cs) | Způsob výroby peptidů | |
| JP2001507027A (ja) | 一般的化学結合 | |
| JP4399627B2 (ja) | 3つまたはそれ以上の成分による化学ペプチド連結 | |
| JPH0632790A (ja) | ビオチン導入試薬およびそれを用いる合成ペプチド精製法 | |
| RU2182155C2 (ru) | Получение очищенных (поли)пептидов | |
| WO2004105685A2 (en) | Displaceable linker solid phase chemical ligation | |
| Whitney et al. | A new base-catalyzed cleavage reaction for the preparation of protected peptides | |
| EP1518862B1 (en) | Solid phase native chemical ligation of unprotected or n-terminal cysteine protected peptides in aqueous solution | |
| JP2005529188A (ja) | オリゴペプチドの化学連結における酸性c末端アミノ酸についてのカルボキシ保護ストラテジー | |
| JP2010537984A (ja) | ポリペプチドおよび蛋白質の化学合成のための方法および中間体 | |
| JP2018145151A (ja) | 多機能型ペプチドプローブ及びこれを用いた標的分子の選択的濃縮法 | |
| JP2777193B2 (ja) | ペプチドの製造方法 | |
| WO2007043615A1 (ja) | ペプチドエステル試薬、およびそのライゲーションまたはチオエステル化合物の製造のための使用 | |
| JPH0297398A (ja) | 固相ペプチド合成におけるpam酵素の使用 | |
| CN113264979A (zh) | 可脱除骨架修饰快速脱除的新方法及应用 | |
| AU2002319850A1 (en) | Improved native chemical ligation with three or more components | |
| Maguire | Novel protecting group strategies for the aspartyl residue in peptide synthesis | |
| Bianchi et al. | Engineering and chemical synthesis of the HCV protease transmembrane protein cofactor NS4A | |
| BURTON | PEPTIDE SEMISYNTHESIS WITH UNBLOCKED BETA (PORCINE)-MSH | |
| AU2002363612A1 (en) | Extended native chemical ligation of three or more peptide fragments |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050607 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050607 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080304 |
|
| A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20080722 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080930 |